Regenlab USA
Pre-clinicalRegenlab develops and markets autologous cell therapy systems for regenerative medicine applications.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $500K
About
Regenlab develops and markets autologous cell therapy systems for regenerative medicine applications.
Biologics
Funding History
1Total raised:$500K
Grant$500KJun 15, 2019